CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD

Sponsor
Punam K Saha (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT03534934
Collaborator
National Institutes of Health (NIH) (NIH), National Heart, Lung, and Blood Institute (NHLBI) (NIH)
560
2
2
75.1
280
3.7

Study Details

Study Description

Brief Summary

The goal of this translational study is to establish a newly emerging CT-based tool for the characterization of changes in bone micro-architecture and assessment of their implications for fracture-risk in a population of COPD patients at risk for osteoporosis. The tool will be suitable and generalizable across emerging CT scanners from different vendors, and it will provide a more structurally-based assessment of osteoporosis and bone loss than is provided by simple bone density measures. The study will characterize the impact of different COPD-related factors on bone structure, and their implications for fracture-risk, leading to the development of a COPD-specific model for assessment of fracture-risk that will utilize patient-specific demographic, clinical and radiographic data, and CT BMD at the spine, as well as bone structural measures at the hip and/or ankle.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Vital signs
  • Diagnostic Test: Urine Pregnancy Test
  • Other: Questionnaires
  • Diagnostic Test: Blood Test
  • Diagnostic Test: Duel-energy X-ray absorptiometry scan
  • Diagnostic Test: Multi-detector computed tomography
  • Diagnostic Test: Dual-energy X-ray absorptiometry scan
N/A

Detailed Description

This translational study seeks to establish a Chronic Obstructive Pulmonary Disease (COPD)-specific fracture prediction model using the investigators unique computed tomography (CT)-based assessment of peripheral bone micro-architecture. Osteoporosis, a common comorbidity among patients with COPD, accelerates morbidity and mortality. The basis for this comorbidity is poorly understood, thus the need for characterizing the link between COPD-related factors and bone micro-architecture and their association to fracture-risk. Multiple COPD-related factors are associated with osteoporosis. Different COPD-related causes of bone loss may non-uniformly impact cortical and trabecular bone structures with varying mechanical consequences, reflective of divergent COPD-associated fracture-risk in individuals with similar bone mineral density (BMD). Little is known about this linkage, and the study goal is to fill this knowledge gap using a clinically suitable emerging CT-based tool for characterization of bone micro-architecture at peripheral sites. Specifically, this study will-(1) establish the generalizability of the investigators bone micro-architecture assessment applied to emerging low dose / high resolution CT scanners from different vendors; (2) assess its potential as compared to dual energy x-ray absorptiometry (DXA) to explain prevalent fractures and predict incident fractures among patients with COPD; (3) quantify the impact of different COPD-related factors on bone structures and their implications for fracture-risk; (4) identify COPD subtypes with rapid bone structural degeneration; and (5) develop a COPD-specific model for assessment of fracture-risk using patient-specific data.

The study will take advantage of-(1) existing COPD patient cohorts with lung characterization at the University of Iowa (UI) and Columbia University (CU) representing a wide demographic range; (2) access to emerging CT scanners at both sites; and (3) unique image processing methodologies for quantifying three-dimensional bone structural metrics. The study will recruit 550 smokers with and without COPD from the UI and CU cohorts of the COPDGene and SPIROMICS studies. Smokers without COPD will comprise the control group for the study. At baseline and 3-year follow-up visits, the study team will collect-(1) data related to risk factors; (2) a lateral spine CT scout scan to assess vertebral fractures; (3) high resolution CT scans of the hip and ankle for computation of bone structural metrics; (4) whole-body, spine and hip DXA scans for evaluation of bone mineral density and body composition; and (5) DXA vertebral fracture assessment.

This study will establish an emerging CT-based scanner-independent generalizable tool to assess bone response to different therapeutic interventions aimed at slowing or reversing bone loss, and possibly restoring bone structure, potentially leading to more patient-specific interventions. Also, this study seeks to explain the relationships among various COPD-related factors, bone structural changes and their implications for fracture-risk.

Finally, a COPD-specific model for assessment of fracture-risk will be developed that will utilize patient-specific demographic, clinical and radiographic data, and CT BMD at the spine, as well as bone structural measures at the hip and/or ankle.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
560 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
All subjects will participate in both baseline and three year follow-up visits and undergo identical interventions.All subjects will participate in both baseline and three year follow-up visits and undergo identical interventions.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD
Actual Study Start Date :
Feb 26, 2019
Anticipated Primary Completion Date :
Jun 1, 2025
Anticipated Study Completion Date :
Jun 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Baseline

Smokers, defined has having at least a 10 pack-year lifetime history, with and without COPD will participate in the following interventions: Vital Signs Urine Pregnancy Test on woman of child bearing potential Pre- and Post-Bronchodilator Spirometry Questionnaires Blood Test for Vitamin D level, Hemoglobin A1c, and creatinine level Duel-energy X-ray absorptiometry scan (DXA) of the whole body, spine, and hip Duel-energy X-ray absorptiometry scan (DXA) for vertebral fracture assessment Multi-detector computed tomography (MDCT) of the hip and ankle

Diagnostic Test: Vital signs
Heart rate, respirations, blood pressure, temperature, oxygen saturation arterial oxygen saturation (SaO2), height and weight

Diagnostic Test: Urine Pregnancy Test
Urine pregnancy test done on woman of childbearing potential.

Other: Questionnaires
Subject Questionnaire Calcium Intake Questionnaire Home and Work Activities Survey

Diagnostic Test: Blood Test
Blood test for vitamin D level, Hemoglobin A1c, and creatinine level

Diagnostic Test: Duel-energy X-ray absorptiometry scan
Bone density measurement
Other Names:
  • DXA scan
  • Diagnostic Test: Multi-detector computed tomography
    Hip and ankle CT scan
    Other Names:
  • MDCT, CT scan
  • Diagnostic Test: Dual-energy X-ray absorptiometry scan
    Vertebral fracture assessment
    Other Names:
  • DXA scan
  • Experimental: 3 year follow-up

    All subjects who completed a baseline visit will return for a follow-up visit and participate in the following interventions: Vital Signs Urine Pregnancy Test on woman of child bearing potential Pre- and Post-Bronchodilator Spirometry Questionnaires Blood Test for Vitamin D level, Hemoglobin A1c, and creatinine level Duel-energy X-ray absorptiometry scan (DXA) of the whole body, spine, and hip Duel-energy X-ray absorptiometry scan (DXA) for vertebral fracture assessment Multi-detector computed tomography (MDCT) of the hip and ankle

    Diagnostic Test: Vital signs
    Heart rate, respirations, blood pressure, temperature, oxygen saturation arterial oxygen saturation (SaO2), height and weight

    Diagnostic Test: Urine Pregnancy Test
    Urine pregnancy test done on woman of childbearing potential.

    Other: Questionnaires
    Subject Questionnaire Calcium Intake Questionnaire Home and Work Activities Survey

    Diagnostic Test: Blood Test
    Blood test for vitamin D level, Hemoglobin A1c, and creatinine level

    Diagnostic Test: Duel-energy X-ray absorptiometry scan
    Bone density measurement
    Other Names:
  • DXA scan
  • Diagnostic Test: Multi-detector computed tomography
    Hip and ankle CT scan
    Other Names:
  • MDCT, CT scan
  • Diagnostic Test: Dual-energy X-ray absorptiometry scan
    Vertebral fracture assessment
    Other Names:
  • DXA scan
  • Outcome Measures

    Primary Outcome Measures

    1. Incident vertebral fractures [Change from baseline and three year follow up visit.]

      Method: Incident vertebral fracture cases between baseline and three-year follow-up visits will be determined by expert visual reading of baseline and three-year follow-up lateral spine CT scout scans.

    2. Prevalent vertebral fractures at baseline [Baseline Visit]

      Method: Prevalent fracture cases at the baseline visit will be determined using expert visual reading of the baseline lateral spine CT scout scan.

    3. CT-based fracture-risk [Baseline Visit]

      Method: Fragility fracture-risk will be computed using a CT-based model comprising of patient-specific demographic, clinical and radiographic data, CT bone mineral density at the spine, and CT bone micro-structural measures at the ankle.

    4. DXA-based fracture risk [Baseline Visit]

      Method: Fragility fracture-risk will be computed using a DXA-based model comprising of patient-specific demographic, clinical and radiographic data, and whole-body, spine, and hip DXA bone mineral density.

    Secondary Outcome Measures

    1. CT bone micro-structural measures at the ankle [Change from baseline and three year follow up visit]

      Method: CT measures of micro-structure at the ankle will be computed using a high-resolution ankle CT scan and computerized algorithms.

    2. CT bone mineral density at the spine [Change from baseline and three year follow up visit]

      Method: CT measures of thoracic spine bone mineral density will be computed using a chest CT scan and computerized algorithms.

    3. DXA Bone Mineral Density [Change from baseline and three year follow up visit.]

      DXA Bone Mineral Density score will be obtained using standard DXA scans.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Current or former smoker, defined as having at least 10-pack year lifetime history

    • Age: 45-90

    Subjects will be stratified into groups based on COPD disease status: smokers with COPD and smokers without COPD.

    Smokers with COPD will be further stratified into three groups: low emphysema (< 3%), moderate emphysema (between 3 and 10%), and severe emphysema (> 10%).

    Exclusion Criteria:
    • Pregnant or breast-feeding

    • Metastatic Malignancy

    • Currently receiving dialysis

    • Any lower extremity fracture within the last year

    • Any lower extremity fracture with hardware implant(s)

    • History of bilateral tibia fractures

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Iowa Hospitals and Clinics Iowa City Iowa United States 52242
    2 Columbia University Medical Center New York New York United States 10032

    Sponsors and Collaborators

    • Punam K Saha
    • National Institutes of Health (NIH)
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Punam Saha, PhD, University of Iowa

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Punam K Saha, Professor, University of Iowa
    ClinicalTrials.gov Identifier:
    NCT03534934
    Other Study ID Numbers:
    • 201802724
    • R01HL142042
    First Posted:
    May 23, 2018
    Last Update Posted:
    Aug 3, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Punam K Saha, Professor, University of Iowa
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 3, 2022